Tioguanine
- Generic Name
- Tioguanine
- Brand Names
- Lanvis, Tabloid
- Drug Type
- Small Molecule
- Chemical Formula
- C5H5N5S
- CAS Number
- 154-42-7
- Unique Ingredient Identifier
- WIX31ZPX66
Overview
An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.
Background
An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.
Indication
For remission induction and remission consolidation treatment of acute nonlymphocytic leukemias.
Associated Conditions
- Acute Non-Lymphocytic Leukemia
- Nonlymphocytic Acute myeloid leukemia
FDA Approved Products
TABLOID
Manufacturer:Waylis Therapeutics LLC
Route:ORAL
Strength:40 mg in 1 1
Approved: 2023/05/15
NDC:80725-630
TABLOID
Manufacturer:Aspen Global Inc.
Route:ORAL
Strength:40 mg in 1 1
Approved: 2022/08/03
NDC:76388-880
TABLOID
Manufacturer:Woodward Pharma Services LLC
Route:ORAL
Strength:40 mg in 1 1
Approved: 2022/04/15
NDC:69784-630
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath